Pharmaceutical - tisagenlecleucel (KYMRIAH)
Ended Awarded
- Contract number
- 36C24921N0367
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $283,556
Award facts
- Contract value 100% obligated
- $283,555.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- East Hanover, NJ 07936, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the pharmaceutical product Kymriah (tisagenlecleucel), a chimeric antigen receptor T-cell (CAR-T) therapy, provided by the prime contractor Novartis Pharmaceuticals Corporation. The contract has a ceiling value of $283,555.92 and is a Blanket Purchase Agreement (BPA) call under Novartis' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract was awarded by the Department of Veterans Affairs (VA) and is intended to support VA medical programs, including the procurement of Kymriah to treat veterans. The contract does not have a set-aside designation. Through its FSS contract and other contract vehicles, Novartis has provided over $2.8 million in Kymriah orders to various VA Integrated Service Networks (VISNs) and medical centers.
Quick answers
Who was awarded contract 36C24921N0367?
36C24921N0367 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 9 (Veterans Health Administration) on March 8, 2021.
How much is contract 36C24921N0367 worth?
The government has obligated $283,556 on 36C24921N0367.
Is contract 36C24921N0367 an order under another contract?
Yes. 36C24921N0367 is a BPA call under 36F79720D0180-36E79720A0019, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24921N0367 competed?
The extent of competition for 36C24921N0367 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award